Skip directly to content

Lyrica® 利痛抑®

Lyrica® 利痛抑®乃一種神經傳遞物抑制劑,透過調節腦內過度活躍的神經細胞發揮功效1。利痛抑®已獲美國食物及藥物監督管理局及歐盟認可2-3

參考資料:​

  1. Lyrica (pregabalin) Prescribing Information. Pfizer Corporation Hong Kong Limited. Version July 2015.
  2. US. Food and Drug Administration. Approved drug products: Lyrica Pregabalin. Available at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseacti.... Accessed on 17 October 2017.
  3. European Medicine Agency. Lyrica Pregabalin authorization details. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medici.... Accessed on 17 October 2017.

 [PAC17033C/OCT]